Healthcare Companies are Racing to Develop Covid-19 Vaccines

It is now expecting that the world will soon have Covid-19 vaccines as around 70 vaccines are under development, of which 3 are already being tested on humans, according to the World Health Organization. Scientists and researchers around the world are working around the clock to develop a vaccine for the novel coronavirus, which has cost millions of lives as well as caused businesses to shut down worldwide.

As scientists race to find a cure for the deadly pathogen, CanSino Biologics Inc. and the Beijing Institute of Biotechnology have completed the development of Covid-19 vaccine and moved to phase 2 of the clinical trial. Alongside, the other vaccines being tested on humans are DNA plasmid vaccine Electroporation device, developed by Inovio Pharmaceuticals, and LNPencapsulated mRNA, which is developed by Moderna/NIAID.

Last month, CanSino received Chinese regulatory approval to begin human trials of its vaccine. Along with, Cambridge, Massachusetts-based Moderna also received a regulatory approval to move quickly to human trials during the same period, skipping the years of animal trials that are typically used in developing vaccines.

In China, Wuhan, where the first coronavirus case was reported in late December 2019, the epicenter of the virus, has been affected more. But with the spread of the virus, Italy got hit hard by the outbreak and reported more deaths in the world. Now, the United States is facing the same situation, maybe worst, as the number of Covid-19 cases across the nation is continuously rising and most importantly, the death toll is climbing high, even surpassed Italy earlier this month. However, experts warn the risk of the outbreak is imminent without a vaccine.

Meanwhile, the unprecedented speed of developing vaccines is hoping to be soon available to the world, as experts say, developing a vaccine for the new coronavirus, SARS-CoV-2, could take at least a year of time to be proven safe, effective and made publicly available. Typically, it takes between 10 to 15 years to get a vaccine out around the world but the drug industry is expecting to reduce the time due to the urgency to prevent the spread of Covid-19.

Japanese pharmaceutical firm AnGes Inc. last month said that the company and Osaka University had developed a DNA vaccine against the Covid-19 pandemic that would start testing in animals soon. Conversely, Takara Bio Co., which provides kits, equipment, and services that assist researchers to discover questions about gene discovery, regulation, and function, is commanding the production of the vaccine.

Moreover, pharmaceutical giants Pfizer and Sanofi have completed the development of vaccine candidates and now in the preclinical stages, according to WHO. In addition, Cobra Biologics, an international contract development and manufacturing organization for biologics and pharmaceuticals, and the Karolinska Institute, a leading medical university in Solna, Sweden, are also have developed vaccines that are in pre-clinical phase now.